Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum.

The College of American Pathologists offers these protocols to assist pathologists in providing clinically useful and relevant information when reporting results of surgical specimen examinations. The College regards the reporting elements in the “Surgical Pathology Cancer Case Summary (Checklist)” portion of the protocols as essential elements of the pathology report. However, the manner in which these elements are reported is at the discretion of each specific pathologist, taking into account clinician preferences, institutional policies, and individual practice. The College developed these protocols as an educational tool to assist pathologists in the useful reporting of relevant information. It did not issue the protocols for use in litigation, reimbursement, or other contexts. Nevertheless, the College recognizes that the protocols might be used by hospitals, attorneys, payers, and others. Indeed, effective January 1, 2004, the Commission on Cancer of the American College of Surgeons mandated the use of the checklist elements of the protocols as part of its Cancer Program Standards for Approved Cancer Programs. Therefore, it becomes even more important for pathologists to familiarize themselves with these documents. At the same time, the College cautions that use of the protocols other than for their intended educational purpose may involve additional considerations that are beyond the scope of this document.

[1]  C. Casella,et al.  Prognostic Variables for Cancer-Related Survival in Node-Negative Colorectal Carcinomas , 2004, Digestive Surgery.

[2]  J. Primrose,et al.  Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists , 2006, British Journal of Cancer.

[3]  D. Sargent,et al.  TN categorization for rectal and colon cancers based on national survival outcome data , 2008 .

[4]  F. Bosman,et al.  WHO Classification of Tumours of the Digestive System , 2010 .

[5]  K. Campbell,et al.  Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. , 2006, Surgery.

[6]  R. Sjödahl,et al.  Local recurrence following total mesorectal excision for rectal cancer , 1996, The British journal of surgery.

[7]  S. Mills,et al.  Sporadic medullary carcinoma of the colon: a clinicopathologic comparison with nonhereditary poorly differentiated enteric-type adenocarcinoma and neuroendocrine colorectal carcinoma. , 2005, American journal of clinical pathology.

[8]  Jeffrey R. Botkin,et al.  Summary of Recommendations: The Evaluation of Genomic Applications , 2022 .

[9]  L. Sobin,et al.  Classification of isolated tumor cells , 2003, Cancer.

[10]  Jong Hoon Kim,et al.  Prognostic Significance of Lymphovascular Invasion in Sporadic Colorectal Cancer , 2010, Diseases of the colon and rectum.

[11]  R. Labianca,et al.  Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  L. Burgart,et al.  Risk of Lymph Node Metastasis in T1 Carcinoma of the Colon and Rectum , 2002, Diseases of the colon and rectum.

[13]  H. Thaler,et al.  Neuroendocrine Carcinomas of the Colon and Rectum , 2004, Diseases of the colon and rectum.

[14]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[15]  S. Larson,et al.  Long-Term Prognostic Significance of Extent of Rectal Cancer Response to Preoperative Radiation and Chemotherapy , 2002, Annals of surgery.

[16]  S. Kakar,et al.  Signet ring cell carcinoma of the colorectum: correlations between microsatellite instability, clinicopathologic features and survival , 2005, Modern Pathology.

[17]  Stanley R. Hamilton,et al.  Pathology and genetics of tumours of the digestive system , 2000 .

[18]  P. Quirke,et al.  Rates of Circumferential Resection Margin Involvement Vary Between Surgeons and Predict Outcomes in Rectal Cancer Surgery , 2002, Annals of surgery.

[19]  Daniel J Sargent,et al.  Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. , 2003, The New England journal of medicine.

[20]  B. O'Sullivan,et al.  Prognostic Factors in Cancer , 1995, UICC International Union Against Cancer / Union Internationale Contre le Cancer.

[21]  S. Stewart-Brown,et al.  Histopathology reporting in large bowel cancer. , 1981, Journal of clinical pathology.

[22]  H. Cooper.  Pathology of the endoscopically removed malignant colorectal polyp , 2007 .

[23]  I. Nagtegaal,et al.  Circumferential Margin Involvement Is Still an Important Predictor of Local Recurrence in Rectal Carcinoma: Not One Millimeter but Two Millimeters Is the Limit , 2002, The American journal of surgical pathology.

[24]  Clive R. Taylor,et al.  Prognostic factors in colorectal cancer , 2009 .

[25]  F. Perner,et al.  Influence of obesity on lymph node recovery from rectal resection specimens , 2009, Pathology Oncology Research.

[26]  V. Moyer,et al.  Lymph node evaluation and survival after curative resection of colon cancer: systematic review. , 2007, Journal of the National Cancer Institute.

[27]  B. Memon,et al.  Outcome of acutely perforated colorectal cancers: experience of a single district general hospital. , 2006, Surgical oncology.

[28]  Kristoffer Derwinger,et al.  Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer , 2010, Acta oncologica.

[29]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[30]  Tomasz Burzykowski,et al.  Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? , 2002, Journal of surgical oncology.

[31]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.

[32]  A. Rashid,et al.  Histopathological identification of colon cancer with microsatellite instability. , 2001, The American journal of pathology.

[33]  J. Silverman,et al.  Pathology of the malignant colorectal polyp. , 1998, Human pathology.

[34]  A. Lièvre,et al.  KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. , 2006, Cancer research.

[35]  P. Conte,et al.  Incidence and Clinical Impact of Sterilized Disease and Minimal Residual Disease After Preoperative Radiochemotherapy for Rectal Cancer , 2005, Diseases of the colon and rectum.

[36]  B. Bellosillo,et al.  A prospective, multicenter, population-based study of BRAF mutational analysis for Lynch syndrome screening. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[37]  K. Hatakeyama,et al.  Number of positive lymph nodes independently affects long-term survival after resection in patients with ampullary carcinoma. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[38]  Y. Cho,et al.  Histological grade predicts survival time associated with recurrence after resection for colorectal cancer. , 2009, Hepato-gastroenterology.

[39]  Hidetaka Mochizuki,et al.  Risk factors for an adverse outcome in early invasive colorectal carcinoma. , 2004, Gastroenterology.

[40]  R. Huynh,et al.  Number of Lymph Nodes Examined and its Impact on Colorectal Cancer Staging , 2006, The American surgeon.

[41]  D. Treanor,et al.  Pathological response following long‐course neoadjuvant chemoradiotherapy for locally advanced rectal cancer , 2005, Histopathology.

[42]  Scott H. Kurtzman,et al.  AJCC cancer staging atlas , 2006 .

[43]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[44]  K. Deen,et al.  Neoadjuvant Therapy for Rectal Cancer Down-Stages the Tumor but Reduces Lymph Node Harvest Significantly , 2004, Surgery Today.

[45]  C. Balch,et al.  AJCC Cancer Staging Manual. 6th ed , 2002 .

[46]  S. Gruber,et al.  Phenotype of Microsatellite Unstable Colorectal Carcinomas: Well‐Differentiated and Focally Mucinous Tumors and the Absence of Dirty Necrosis Correlate With Microsatellite Instability , 2003, The American journal of surgical pathology.

[47]  T. Mattfeldt,et al.  Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients. , 1999, Archives of surgery.

[48]  N. Goldstein.  Lymph Node Recoveries From 2427 pT3 Colorectal Resection Specimens Spanning 45 Years: Recommendations for a Minimum Number of Recovered Lymph Nodes Based on Predictive Probabilities , 2002, The American journal of surgical pathology.

[49]  K. Batts,et al.  Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. , 2005, American journal of clinical pathology.

[50]  C. Ratto,et al.  Prognostic factors in colorectal cancer , 1998, Diseases of the colon and rectum.

[51]  A. Pollett,et al.  Prognostic significance of mesenteric tumor nodules in patients with stage III colorectal cancer. , 2006, Cancer.

[52]  Ch. Wittekind,et al.  TNM supplement : a commentary on uniform use , 2003 .

[53]  J. Jass,et al.  Clinicopathological staging for colorectal cancer: An International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT) , 1991, Journal of gastroenterology and hepatology.

[54]  J. Jass,et al.  Pathology of hereditary non-polyposis colorectal cancer. , 1994, Anticancer research.

[55]  R. Haggitt,et al.  Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. , 1985, Gastroenterology.

[56]  C. Fenoglio-Preiser,et al.  Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential , 1989, Cancer.

[57]  B. Vogelstein,et al.  Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. , 1994, The American journal of pathology.

[58]  Daniel J. Freeman,et al.  Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  R. Parks,et al.  Presentation, treatment and outcome in patients with ampullary tumours , 2004, The British journal of surgery.

[60]  M E Hammond,et al.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. , 2000, Archives of pathology & laboratory medicine.

[61]  C. Ko,et al.  A 10-Year Outcomes Evaluation of Mucinous and Signet-Ring Cell Carcinoma of the Colon and Rectum , 2005, Diseases of the colon and rectum.

[62]  D. L. Lamm,et al.  Carcinoma in situ. , 1992, The Urologic clinics of North America.

[63]  Brian O'Sullivan,et al.  Prognostic factors in cancer. , 2003 .

[64]  Sudhir Srivastava,et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.

[65]  O. Dent,et al.  Adverse histopathological findings as a guide to patient management after curative resection of node‐positive colonic cancer , 2004, The British journal of surgery.

[66]  S. Gallinger,et al.  Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. , 2006, Journal of the American College of Surgeons.

[67]  D. Henson,et al.  Tumors of the Gallbladder, Extrahepatic Bile Ducts and Ampulla of Vater , 2000 .

[68]  Carcinoma of the colon and rectum. , 1962 .

[69]  N. Ohkohchi,et al.  Patterns and Predictors of Failure after Curative Resections of Carcinoma of the Ampulla of Vater , 2003, Annals of Surgical Oncology.

[70]  E. Gilpin,et al.  Factors influencing survival after resection for periampullary neoplasms. , 2000, American journal of surgery.

[71]  J. Huh,et al.  Prognostic Value of Perineural Invasion in Patients with Stage II Colorectal Cancer , 2010, Annals of Surgical Oncology.

[72]  Randall G. Lee,et al.  High prevalence of adenomatous polyps of the duodenal papilla in familial adenomatous polyposis , 1989, Digestive Diseases and Sciences.

[73]  J. Cuzick,et al.  The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases , 1986, Histopathology.

[74]  P. Conesa‐Zamora,et al.  Clinicopathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma. , 2010, Human pathology.

[75]  K. Yoshimura,et al.  Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection , 2003, Journal of surgical oncology.

[76]  Y. Shan,et al.  Predictors for Patterns of Failure after Pancreaticoduodenectomy in Ampullary Cancer , 2006, Annals of Surgical Oncology.

[77]  Hiroyuki Yamamoto,et al.  BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes , 2005, Oncogene.

[78]  Rieken,et al.  [Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer]. , 2001, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[79]  J. Jass.  Pathology of Hereditary Nonpolyposis Colorectal Cancer , 2000, Annals of the New York Academy of Sciences.

[80]  M. Risio,et al.  Malignant adenoma: diagnosis, staging, risk factors, lymph node involvement and problems of sampling , 2004, Techniques in Coloproctology.

[81]  D. Berger,et al.  Perineural invasion is an independent predictor of outcome in colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[82]  S B Love,et al.  The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. , 1997, Gastroenterology.

[83]  R. Houlston,et al.  Interobserver agreement in grading of colorectal cancers—findings from a nationwide web‐based survey of histopathologists , 2008, Histopathology.

[84]  G. Pelosi,et al.  Pathological assessment of pericolonic tumor deposits in advanced colonic carcinoma: relevance to prognosis and tumor staging , 2007, Modern Pathology.

[85]  Seung-Yong Jeong,et al.  Indications for Subsequent Surgery After Endoscopic Resection of Submucosally Invasive Colorectal Carcinomas: A Prospective Cohort Study , 2009, Diseases of the colon and rectum.

[86]  M. Schwartz,et al.  Colorectal adenocarcinoma with micropapillary pattern and its association with lymph node metastasis , 2007, Modern Pathology.

[87]  References , 1971 .

[88]  J. Silverman,et al.  Endoscopically removed malignant colorectal polyps: clinicopathologic correlations. , 1995, Gastroenterology.